Sanofi SNY
NASDAQ SNY
$41.60 -0.36 (-0.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

Sanofi (SNY) Interest & Investment Income (2009 - 2026)

Updated

Sanofi (SNY) recorded Interest & Investment Income of $89.5 million in the quarter ended Jun 30, 2026, down 19.3% from $110.93 million a year earlier but up 27.4% from the prior quarter.

Analysis

Sanofi (SNY) Interest & Investment Income (2009 - 2026) Analysis & Trends

On a TTM basis, Sanofi's Interest & Investment Income came in at $161.24 million as of Jun 30, 2026, down 64.8% year-over-year; for the year ended Dec 31, 2025, it was $445.15 million, down 20.8% from the prior year.

  • Annual Interest & Investment Income has a five-year compound annual growth rate of 49.0% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Interest & Investment Income came in at $561.73 million in the year ended Dec 31, 2024 (-11.1%), $631.72 million in the year ended Dec 31, 2023 (+192.4%), $216.06 million in the year ended Dec 31, 2022 (+356.4%) and $47.34 million in the year ended Dec 31, 2021 (-21.8%).
  • Quarterly Interest & Investment Income has ranged from -$346.88 million in the quarter ended Dec 31, 2025 to $348.38 million in the quarter ended Sep 30, 2025 over the past five years.
  • On a year-over-year basis, Interest & Investment Income rose in 1 of the last seven quarters, with an average decline of 0.6%.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 970.2% in the quarter ended Dec 31, 2022, against a decline of 86.5% in the quarter ended Sep 30, 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $70.24 million (quarter ended Mar 31, 2026), -$346.88 million (quarter ended Dec 31, 2025) and $348.38 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 186.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 80.00 Mn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Sanofi 50.73 Bn 17.66 Bn 10.79 Bn 89.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 89.50 Mn
Mar 31, 2026 70.24 Mn
Dec 31, 2025 -102.44 Mn
Sep 30, 2025 348.38 Mn
Jun 30, 2025 110.93 Mn
Mar 31, 2025 90.46 Mn
Dec 31, 2024 112.20 Mn
Sep 30, 2024 143.87 Mn
Jun 30, 2024 140.00 Mn
Mar 31, 2024 159.70 Mn
Dec 31, 2023 166.77 Mn
Sep 30, 2023 155.67 Mn
Jun 30, 2023 136.12 Mn
Mar 31, 2023 172.81 Mn
Dec 31, 2022 122.43 Mn
Sep 30, 2022 52.43 Mn
Jun 30, 2022 25.61 Mn
Mar 31, 2022 11.22 Mn
Dec 31, 2021 11.44 Mn
Sep 30, 2021 2.36 Mn
API Access

Sanofi Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SNY&period=max&api_key=YOUR_API_KEY